Longer use of Valcyte for renal transplant patients approved - ONA
Links shared publicly online about this topic.
- 955total visits
Longer use of Valcyte for renal transplant patients approved - ONA
View full resource at oncologynurseadvisor.com
Tags: Kidney Health, Urinary System, Disease and Condition, FDA, Genentech, Transplantation, disease
Most Recently Shared on August 11, 2010 at 2:45 pm By:
Longer use of Valcyte for renal transplant patients approved http://goo.gl/fb/EXdKT
Longer use of Valcyte for renal transplant patients approved - MPR
empr.com — “The FDA has approved a longer duration of therapy with Valcyte (valganciclovir, from Genentech) in adult renal transplant patients at high risk for cytomegalovirus (CMV) disease.” View full resource at empr.com
Most Recently Shared on August 11, 2010 at 2:49 pm By:
MPR News: Longer use of Valcyte for renal transplant patients approved: The FDA has approved a longer duration of ... http://bit.ly/dcHHe5
MarketWatch.com
marketwatch.com — “MarketWatch.com” View full resource at marketwatch.com
Most Recently Shared on August 10, 2010 at 10:27 pm By:
The Kidney Group Physician Group and Nephrology
FDA approves longer use of Valcyte in kidney transplant patients at high risk of CMV infection.http://bit.ly/b1tdgx
Advertisement
